Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This prospective observational study assesses whether women who regularly exercise during pregnancy show reduced low grade Inflammation, compared to women who are not regularly exercising. Furthermore, the effects of regular physical activity in pregnancy on fetal and neonatal outcomes will be investigated. 3 groups of pregnant women will be formed (group 1: regularly physically active women; group 2: physically inactive women and group 3: women with a history of preeclampsia or positive history of metabolic conditions increasing the risk of hypertensive disorders in pregnancy).
Pregnancy is a natural state of low grade inflammation in the mother and the feto-placental unit. The severity of this inflammation increases with higher pregravid Body Mass Index (BMI). This is reflected by an increase in pro-inflammatory cytokines in the maternal circulation and in the placenta. It has been proposed that the pro-inflammatory maternal and fetal environment plays a role in mediating pregnancy outcomes.
In non-pregnant individuals regular physical activity is associated with a reduced inflammatory state. The overall objective of the study is to investigate the interaction of maternal physical activity and pregnancy induced low-grade inflammation in the mother and feto-placental unit, and to assess th resulting effects on prenatal and postnatal development.
Specific research objective will be to study effects of maternal physical activity on:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Active | pregnant women who are physically active (spend a minimum of 150min/week with moderate to vigorous physical activity) | ||
| Inactive | pregnant women who are physically inactive (spend less than 150min/week with moderate to vigorous physical activity) | ||
| risk for hypertensive disorders | pregnant women with a history of preeclampsia or positive history for metabolic conditions increasing the risk of hypertensive disorders in pregnancy |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| low grade inflammation (in maternal and cord blood) | clinical inflammation markers: C-reactive protein, cytokines and chemokine (IL1b, IL1a, IL-2, IL-5, IL-6,IL-12, TNFa, MCP-1, MIP1-a) measured by ELISA and multiplexing arrays | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| maternal and fetal (cord blood) lipid profiles | triglycerides, phospholipids, free fatty acids, HDL/LDL/total cholesterol | 1 year |
| neonatal body composition (% body fat) | measured by air displacement plethysmography (Peapod) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Women with an ongoing healthy pregnancy. 3 groups will be formed: Group1 consists of women performing moderate to vigorous physical activity (PA) before and in early pregnancy. Group2 consists of women who are not physically active, and Group3 consists of women with a risk of hypertensive disorders or metabolic diseases (not diabetes). PA before and in early pregnancy will be assessed with a screening questionnaire. Women reporting a minimum of 150 mins of moderate to vigorous PA per week will be classified as active, women with less PA will be classified as inactive. 20 women each group will be recruited not later than 14 weeks of gestation. Women will be recruited at the outpatient clinic at the Department of Obstetrics and Gynecology, Medical University of Graz.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bence Csapo, MD | Medical University of Graz | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
maternal venous blood (serum /plasma), cord blood (serum /plasma); placenta tissue (RNA later);
| 1 year |
| maternal and newborn fat distribution | subcutaneous adipose tissue thickness at 15 defined body sites, measured by a lipometer | 1 year |
| fetal growth | measured by ultrasound scanner | 1 year |
| transcriptome of the placenta | measured by full genome arrays | 2 years |
| epigenetic analysis of the placenta | analysed by 450k methylation arrays | 2 years |
| biomarkers of nutritional status | measurement of blood levels of fatty acids (DHA, EPA, 15:0, 17:0), vitamin A, B1, B2, B6, D2/D3, C, E, homocysteine | 2 years |
| psychological assessment | assessment of arterial stiffness, stress coping questionnaire, cardiac awareness | 1 year |